Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
glp-1 agonist therapy consultation preparation Optimizing therapies for obesity and diabetes management Ensuring Quality and Efficacy Quantity:3-Month Supply (90 servings) GLP-1 Support
Ensuring Quality and Efficacy of GLP-1 Agonists: Analytical Challenges and Solutions in Therapeutic Peptide Production - Emery Pharma
It possesses in vitro balanced GIPR (EC50 = 3 pM) and GLP-1R (EC50 = 5 pM) agonism with relative activity seven times that of GIP to GIPR and five times that of GLP-1 to GLP-1R, respectively ( max at 5.4 nM with a single dose of 1.8 mg (106) and C max at 12 nM at the steady state with a daily dose of 2 mg in patients with T2DM (107)
GLP-1 Support
Quantity:3-Month Supply (90 servings)
Adult obesity has stopped rising, but severe obesity has not Overall adult obesity has been flat across the past decade of CDC measurement, while severe obesity rose from 7.7% to 9.7% 42
US$ 21.56
US$ 29.84
US$ 23.53
US$ 21.97
US$ 22.04
